More Immutep Ltd news Immutep LtdASX: IMM Approval received to commence 3rd cohort of melanoma trial Apr 19, 2017 at 4:30 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
